In view of that activation of NF-κB participates in the pulmonary inflammatory reaction of COPD patients and maintains it for a long time, many researchers have believed that t NF-κB could be used as the primary target of COPD. Here, NFKB1 is linked to chronic obstructive pulmonary disease.